Clinical Trials Directory

Trials / Completed

CompletedNCT02980913

Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye Syndrome

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Dry eye syndrome is a highly prevalent ocular disease with an increasing incidence in the elderly population. Topically administered lubricants are the basis for treatment of this disease. Relief of symptoms in patients with moderate to severe dry eye disease is usually reached by the use of artificial tears during the day. Nighttime relief is often achieved by substances known to be more adhesive to the ocular surface, such as gels.

Conditions

Interventions

TypeNameDescription
DEVICEThealoz Duo eye drops and Thealoz Duo gelThealoz Duo eye drops during the day + Thealoz Duo gel at night (1 drop before going to bed) for 7 days
DEVICEThealoz Duo gelThealoz Duo gel during the day and at night for 7 days

Timeline

Start date
2016-02-11
Primary completion
2016-05-17
Completion
2016-05-17
First posted
2016-12-02
Last updated
2019-08-22

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT02980913. Inclusion in this directory is not an endorsement.

Difference in the Frequency of Use of Lachrymal Substitutes in Patients With Moderate to Severe Dry Eye Syndrome (NCT02980913) · Clinical Trials Directory